Smart ECM
RESDoc Congress SrlEvento 482645 / Edizione 1

Respiration day 2026 - Chronic airway diseases and their comorbidities

Congresso residenziale a Parma su BPCO, asma, bronchiectasie e comorbidità respiratorie, rivolto a medici specialisti con aggiornamento su diagnosi, terapie biologiche e ricerca traslazionale.

Questo evento si è concluso il 27 giugno 2026.

Provider
Doc Congress SrlDoc Congress Srl (246)
Crediti ECM
3
Costo
350,00 €
Durata
10 ore
Date
26 - 27 giugno 2026

Razionale scientifico

The aim of the 2026 Edition of "Respiration Day" is to provide the view of where the Respiratory clinicians and researchers are and where they are heading in the field of chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis and their comorbidities, and the role of small airway diseases in these respiratory diseases. The invited members of the Faculty are among the most productive international clinical scientists in the field chronic airway diseases, the audience will be 350 national top national clinical opinion leaders selected from more than 20 countries. The main aim of the meeting is educational, and the speakers have been specifically invited to translate in their lectures the most important recent discoveries to the potential improvement of clinical practice. A significant proportion of time (40%) will be devoted to discussion. The Meeting is divided in 5 sessions. The first session will focus on the recent advancements in COPD and its comorbidities, and in particular the first lecture will focus on the need to better characterize the different phenotypes included under the umbrella of the term COPD, both in term of etiology and clinical presentation, early diagnosis, and active search of multimorbidity to improve the management of individual patients. The second lecture will be devoted to novel therapies for COPD, particularly the biologics, with the aim of improved comprehensive and personalized management. The third lecture will focus on the major cardiovascular risk in patients with COPD, both in stable and during and in the aftermath of exacerbations of respiratory symptoms. The second session will focus on asthma as a disease of both central and peripheral airways, the need of integration of traditional pharmacological inhalation treatments with systemic agents and/or biologics, the third the ongoing research focused on mechanisms rather than clinical treatable traits. The third session will be devoted to the importance and impact of small airways dysfunction for chronic airway diseases, and in particular on the fundamental role of inhalers but also of their environmental impact, its complex impact on respiratory and non-respiratory components of chronic airway diseases, and last, but not least, how can AI help us to understand the role of small airways dysfunction. The fourth session will be devoted to the novel discoveries in the field of pathology of chronic airway diseases, and particularly the importance of mucus plugs, and mucociliary clearance. Finally the fifth session will be devoted to bronchiectasis that in the last 15 years has been discovered to represent not only a treatable trait of other chronic airway diseases but also an independent treatable disease.

Luogo

Starhotels Du Parc
Via Piacenza 12/c, Parma (PR)

Programma

26 June 2026
  • 07:45 – 08:15Registration of the delegates
  • 08:15 – 09:00Welcome SessionProf. Dario Olivieri, Prof. Gaetano Caramori, Prof. Paolo Martelli
  • 09:00 – 09:25Novel approaches to the diagnosis and assessment of severity of multimorbid COPDSurya Bhatt (Birmingham)
  • 09:25 – 09:50Novel approaches to the pharmacologic management of multimorbid COPDBartolome Celli (Boston)
  • 09:50 – 10:15Cardiovascular risk in stable and exacerbated multimorbid COPDFilippo Crea (Rome)
  • 10:15 – 11:00Discussion
  • 11:00 – 11:30Coffee break
  • 11:30 – 11:55Pulmonary pathology of asthma, COPD and chronic bronchitis: role of small airwaysGuy Brusselle (Ghent)
  • 11:55 – 12:20Integrated pharmacologic and biologic treatment of severe asthmaMatteo Bonini (Rome)
  • 12:20 – 12:55Mechanism directed treatment in chronic airway diseasesKlaus Rabe (Kiel)
  • 12:55 – 13:30Discussion
  • 13:30 – 14:30Lunch
  • 14:30 – 14:55Early origins of asthma: What happens to the airways?Erika Von Mutius (Munich/Boston)
  • 14:55 – 15:20Pathophysiology of small airway diseases (SAD)Omar Usmani (London)
  • 15:20 – 15:55Artificial intelligence in chronic airway diseasesAlvar A Agusti (Barcelona)
  • 15:55 – 16:40Discussion
  • 16:40 – 17:00Coffee break
  • 17:00End of Day 1
27 June 2026
  • 09:00 – 09:25Clinical role of central and peripheral airway diseases in asthmaMaarten Van den Berge (Groningen)
  • 09:25 – 09:50Mucus plugs in chronic airway diseasesAlejandro A. Diaz (Boston)
  • 09:50 – 10:15The pathobiology and treatment of mucus plugs in asthma and COPDJohn Fahy (San Francisco)
  • 10:15 – 11:00Discussion
  • 11:00 – 11:30Coffee break
  • 11:30 – 11:55Novel approaches to the diagnosis and assessment of severity of bronchiectasisStefano Aliberti (Milan)
  • 11:55 – 12:20Novel approaches to the pharmacologic management of bronchiectasisMichal Shteinberg (Haifa)
  • 12:20 – 12:55Mechanism directed treatment approach: triple therapy in cystic fibrosisPierre Regis Burgel (Paris)
  • 12:55 – 13:30Discussion
  • 13:30Take-home messages and conclusions

Responsabili del corso

DOC CONGRESS SRL

Provider

ID Provider: N° 246

Città: Milano (MI)

Tipologia: Società, Agenzie Ed Enti Privati

Stato accreditamento: Standard - 2° Rinnovo

  • Prof. Dario Olivieri

    Responsabile scientifico

    Specializzazione: Docente Presso L'Universita' di Parma

    Struttura: Università di Parma

    Ruolo: Professor of Respiratory Disease

Relatori e docenti

  • Alvar Agusti

    Relatore

    Specializzazione: Respiratory Medicine

    Struttura: University of Barcelona and Hospital Clinic, Barcelona, Spain

    Ruolo: Professor of Medicine at the University of Barcelona and senior consultant at Hospital Clinic

  • Stefano Aliberti

    Relatore

    Specializzazione: Malattie dell'Apparato Respiratorio

    Struttura: Humanitas University, Milan, Italy

    Ruolo: Direttore del Programma di Fellowship in Malattie dell'Apparato Respiratorio, Dipartimento di Scienze Biomediche

  • Surya Bhatt

    Relatore

    Specializzazione: Internal Medicine

    Struttura: University of Alabama, Birmingham, UK

    Ruolo: Professor of Medicine - Pulmonary, Allergy, & Critical Care Medicine

  • Matteo Bonini

    Relatore

  • Guy Brusselle

    Relatore

Domande frequenti

L'evento è accreditato per: Medico Chirurgo (Allergologia Ed Immunologia Clinica, Malattie Dell'apparato Respiratorio, Medicina Interna, Medicina Generale (Medici Di Famiglia), Medicina Del Lavoro E Sicurezza Degli Ambienti Di Lavoro).

Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Smart ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.

Sei un provider ECM?

Contattaci per scoprire come possiamo collaborare.

Contattaci